EUVIMEDEUVIMED entdecken
Crossref

1‐Kestose Prevents Psychiatric‐Like Behavior by Enhancing Short‐Chain Fatty Acid Production

Moeka Tanabe iD, Kazuo Kunisawa iD, Tadashi Fujii, Takumi Tochio, Yoshiki Hirooka, Haruto Ojika, Yuta Naruoka, Hiroyasu Ito, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri iD

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Moeka Tanabe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Scien…. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Trisaccharides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Smoking Research Foundation, Japan Science and Technology Agency, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychiatric disorders such as major depressive disorder are closely linked to the intestinal environment, suggesting intestinal health may contribute to their prevention. Prebiotics, which enhance intestinal health, are promising candidates for preventing psychiatric disorders. 1‐Kestose (kestose), a type of prebiotics, has shown potential, but its effects on psychiatric disorders remain unclear. In this study, we investigated whether kestose prevents abnormal behaviors induced by social isolation (SI) stress and which underlies mechanisms of preventive effects. C57BL/6J male mice (3 weeks old) were divided into two groups: individually housed (SI) group and housed five mice per cage (GH) group. Each group received either a normal diet or a kestose diet (5% kestose) for 5 weeks daily until the end of the behavioral testing. Kestose prevented the SI‐induced abnormal behaviors including reduced sociality, impaired spatial recognition, and heightened anxiety, which were associated with suppressed microglial activation in the hippocampus. Kestose altered the diversity of gut microbiota and increased the abundance of Bacteroides sartorii . Furthermore, short‐chain fatty acids (SCFAs) such as butyric acid, acetic acid, and propionic acid, produced by intestinal microbiota, were increased after kestose supplementation. Positive correlations were observed between B. sartorii abundance and SCFA levels, suggesting that B. sartorii contributes to SCFA production. Notably, both B. sartorii and SCFAs were strongly associated with the abnormal behaviors by SI. These findings suggest that kestose prevents SI‐induced abnormal behaviors by modulating gut microbiota, particularly B. sartorii , through an increase of SCFA production. Taken together, kestose could be used as a promising prebiotic intervention for psychiatric disorders. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, VolatileTrisaccharidesAnimalsMaleMiceMice, Inbred C57BLGastrointestinal MicrobiomeSocial IsolationBehavior, AnimalStress, PsychologicalPrebioticsHippocampus

Stichwörter der Autor:innen

1‐kestosegut microbiotaprebioticspsychiatric disordersshort‐chain fatty acids

Substanzen

Fatty Acids, VolatileTrisaccharidesPrebiotics

Autor:innen und Institutionen

  • Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Sciences, Toyoake, Aichi, Japan.
  • Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Medical Science, Toyoake, Aichi, Japan.
  • Department of Disease Systems Analysis Medicine, Fujita Health University School of Medical Sciences, Toyoake, Aichi, Japan.
  • Division of Neuroimmunology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Aichi, Japan.
  • Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe), Toyoake, Aichi, Japan.
  • Japanese Drug Organization of Appropriate Use and Research (J-DO), Nagoya, Aichi, Japan.

ORCID-Profile: Moeka Tanabe, Kazuo Kunisawa, Akihiro Mouri

Förderung

  • Smoking Research Foundation
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science

Zitieren

APA

Tanabe, M., Kunisawa, K., Fujii, T., Tochio, T., Hirooka, Y., Ojika, H., Naruoka, Y., Ito, H., Saito, K., Nabeshima, T., & Mouri, A. (2025). 1‐Kestose Prevents Psychiatric‐Like Behavior by Enhancing Short‐Chain Fatty Acid Production. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70273

Vancouver

Tanabe M, Kunisawa K, Fujii T, Tochio T, Hirooka Y, Ojika H, et al. 1‐Kestose Prevents Psychiatric‐Like Behavior by Enhancing Short‐Chain Fatty Acid Production. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70273

BibTeX
@article{Tanabe2025,
  author = {Tanabe, Moeka and Kunisawa, Kazuo and Fujii, Tadashi and Tochio, Takumi and Hirooka, Yoshiki and Ojika, Haruto and Naruoka, Yuta and Ito, Hiroyasu and Saito, Kuniaki and Nabeshima, Toshitaka and Mouri, Akihiro},
  title = {1‐Kestose Prevents Psychiatric‐Like Behavior by Enhancing Short‐Chain Fatty Acid Production},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70273}
}
Kostenlos starten →